Table 2.
Clinical characteristics of patients treated with propranolol or timolo.
| Propranolol | Timolol | P-value | |
|---|---|---|---|
| group | group | ||
| Age (months) | 6.1 | 5.4 | 0.62 |
| Gender | 0.74 | ||
| Male | 93 | 98 | |
| Female | 269 | 264 | |
| Lesion location | 0.18 | ||
| Head and neck | 221 | 200 | |
| Extremities | 81 | 84 | |
| Trunk | 60 | 78 | |
| Lesion size | 0.21 | ||
| 0–5 cm2 | 235 | 251 | |
| ≧5 cm2 | 127 | 111 | |
| Gestational age | 0.71 | ||
| Tern born (≧37 weeks) | 289 | 284 | |
| Born prematurely (< 37 weeks) | 73 | 78 | |
| Progesterone use during pregnancy | 0.48 | ||
| Yes | 38 | 45 | |
| No | 324 | 317 | |
| Duration of treatment (months) | 6.0 | 7.3 | 0.23 |
| Follow-up time (months) | 6.2 | 6.5 | 0.27 |